HRAS and liver cancer: Next, to demonstrate whether individual modulation of ADAR1, MSI2, and SLC38A4 affects liver tumorigenesis in vivo, we prepared H-ras-transgenic mice that spontaneously develop liver cancer beginning at ~14 weeks of age13.